Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Tirzepatide for Sale > Tirzepatide 99.2% purity High Quality weight loss hot sale tirzepatide door to door
Tirzepatide 99.2% purity High Quality weight loss hot sale tirzepatide door to door buy - large image1
Tirzepatide 99.2% purity High Quality weight loss hot sale tirzepatide door to door buy - image1
Tirzepatide 99.2% purity High Quality weight loss hot sale tirzepatide door to door buy - image2
Tirzepatide 99.2% purity High Quality weight loss hot sale tirzepatide door to door buy - image3
Tirzepatide 99.2% purity High Quality weight loss hot sale tirzepatide door to door buy - image4
Tirzepatide 99.2% purity High Quality weight loss hot sale tirzepatide door to door buy - image5
Tirzepatide 99.2% purity High Quality weight loss hot sale tirzepatide door to door buy - image6

Tirzepatide 99.2% purity High Quality weight loss hot sale tirzepatide door to door

COA 2103 Inquiries

Unit Price: Get Latest Price
CAS No.:

2023788-19-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

ningbo

Brand:

peijia

Packaging:

10mg 20mg 30mg per vial;10vials/box

Sample Available:

Yes

Price valid (until):

2026-06-29

Company Type:
Trader
Location:
China
Qualification:
Main Products:

peptide

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Name: Hayley

    WA: +8 52     69975972

    Email: lihayley56@gmail.com

    sincerely look forward to your inquiries about our products.

    Premium Quality for Research, Development, and Industrial Applications
    As a trusted global supplier, we provide a comprehensive range of high-purity peptides and biochemical compounds to support scientific innovation and product development. Our portfolio is designed for researchers, formulators, and manufacturers who require reliable, high-quality materials.

      • Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that is being developed for the treatment of type 2 diabetes. Tirzepatide (LY3298176) shows significantly better efficacy with regard to glucose control and weight loss than do Dulaglutide. Tirzepatide, also known as LY 3298176, is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide has a greater affinity to GIP receptors than to GLP-1 receptors, and this dual agonist behavior has been shown to produce greater reductions of hyperglycemia compared to a selective GLP-1 receptor agonist. Signaling studies reported that tirzepatide mimics the actions of natural GIP at the GIP receptor. Tirzepatide was approved for improving blood sugar control in adults with type 2 diabetes, as an addition to diet and exercise.

        1. Ultra-High Purity

        Each batch is synthesized and purified to >99% purity, ensuring reliable and reproducible results in sensitive experiments.

        2.Accurate Dosing & Consistency
        Our peptides are precisely weighed and vacuum-sealed under sterile conditions. Batch-to-batch consistency is rigorously maintained.

        3.Endotoxin-Free & Sterile Processing
        Manufactured in a cleanroom environment, our peptides are free from endotoxins, microbial contamination, and other impurities that could interfere with cell-based or in vivo studies.

      •  Our company adheres to the business philosophy of integrity and cooperation. scientific innovation and service first.With absolute quality assurance as the purpose and perfect service system as the basis, our company provides efficient and satisfactory consulting services, sincerely welcomes your business inquiries,and looks forward to working with you to create a new future.

        Key Products:
        Our primary focus encompasses a range of products, including weight loss peptides, medicinal peptides, cosmetic peptides, and customized peptides. Notable among our weight loss peptide offerings are Semaglutide, Tirzepatide, Retatrutide, and others.

    Shop MT-2 Melanotan 2Acetate peptide Wholesale price Factory price top quality-Detailed Image 1
    Shop MT-2 Melanotan 2Acetate peptide Wholesale price Factory price top quality-Detailed Image 2
    Shop MT-2 Melanotan 2Acetate peptide Wholesale price Factory price top quality-Detailed Image 3
    Shop MT-2 Melanotan 2Acetate peptide Wholesale price Factory price top quality-Detailed Image 4
    Shop MT-2 Melanotan 2Acetate peptide Wholesale price Factory price top quality-Detailed Image 6
    Shop MT-2 Melanotan 2Acetate peptide Wholesale price Factory price top quality-Detailed Image 7
    Shop Mazdutide 10mg Raw Powder  Door To Door Service-Detailed Image 8
    Shop Mazdutide 10mg Raw Powder  Door To Door Service-Detailed Image 9
    Shop Mazdutide 10mg Raw Powder  Door To Door Service-Detailed Image 10
    Appearance Powder
    Purity >99%  (or refer to the Certificate of Analysis)
    Origin China
    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Certificates

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    peptide

    Location:

    Hangzhou Peijia E-commerce Co., LTD

    Year of Establishment:

    2026

  • Inquiry History
    2103 Inquiries
    Country Product Purchase Quantity Date Posted
    Brazil

    Tirzepatide

    100 G Oct 28, 2026
    Belgium

    Tirzepatide

    10 MG Oct 28, 2026
    United States

    tirzepatide

    100 MG Oct 28, 2026
    United States

    Tirzepatide

    60 MG Oct 28, 2026
    United States

    Tirzepatide

    10 PCS Oct 28, 2026
    United States

    tirzepatide

    30 MG Oct 27, 2026
    United States

    Tirzepatide

    40 MG Oct 27, 2026
    Philippines

    Tirzepatide

    2 MT Oct 27, 2026
    Philippines

    Tirzepatide

    30 MG Oct 26, 2026
    Slovakia

    Tirzepatide

    1 G Oct 26, 2026
    France

    Tirzepatide

    1 KG Oct 25, 2026
    United States

    Tirzepatide

    2.5 MG Oct 25, 2026
    United Kingdom

    Tirzepatide

    5 MT Oct 25, 2026
    United Kingdom

    Tirzepatide

    6 MT Oct 24, 2026
    Peru

    tirzepatide

    10 MG Oct 21, 2026
    Puerto Rico

    tirzepatide

    40 MG Oct 21, 2026
    United States

    Tirzepatide

    10 MT Oct 21, 2026
    South Africa

    Tirzepatide

    1 MT Oct 20, 2026
    United States

    Tirzepatide

    5 KG Oct 20, 2026
    United States

    tirzepatide

    30 MG Oct 20, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.